These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23514835)

  • 1. Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.
    Webster DP; Wojcikiewicz T; Keller M; Castelnovo D; Mistry H; Gilleece Y; Tibble J; Fisher M
    Int J STD AIDS; 2013 Mar; 24(3):179-83. PubMed ID: 23514835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study.
    Piroth L; Larsen C; Binquet C; Alric L; Auperin I; Chaix ML; Dominguez S; Duval X; Gervais A; Ghosn J; Delarocque-Astagneau E; Pol S;
    Hepatology; 2010 Dec; 52(6):1915-21. PubMed ID: 21064156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute hepatitis C in an HIV-positive man with pegylated interferon and ribavirin for 24 weeks.
    Rafiq N; Carriero D; Uriel A; Dieterich DT
    AIDS Read; 2007 Nov; 17(11):561-4. PubMed ID: 18170920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
    Colson P; Bregigeon S; Tourres C; Solas C; Poizot-Martin I; Tamalet C
    J Clin Virol; 2013 Sep; 58(1):309-14. PubMed ID: 23810614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration.
    Lambers FA; Brinkman K; Schinkel J; Spijkerman IJ; Molenkamp R; Coutinho RA; Prins M; van der Meer JT;
    AIDS; 2011 Jun; 25(10):1333-6. PubMed ID: 21516025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma interferon-gamma-inducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1.
    Vargas A; Berenguer J; Ryan P; Catalán P; López JC; Cosín J; Miralles P; Resino S
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):219-20. PubMed ID: 20505475
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.
    Steininger K; Boyd A; Dupke S; Krznaric I; Carganico A; Munteanu M; Neifer S; Schuetze M; Obermeier M; Arasteh K; Baumgarten A; Ingiliz P
    J Viral Hepat; 2017 Oct; 24(10):832-839. PubMed ID: 28439936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study.
    Ishikane M; Watanabe K; Tsukada K; Nozaki Y; Yanase M; Igari T; Masaki N; Kikuchi Y; Oka S; Gatanaga H
    PLoS One; 2014; 9(6):e100517. PubMed ID: 24945812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
    HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
    TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
    Ingiliz P; Martin TC; Rodger A; Stellbrink HJ; Mauss S; Boesecke C; Mandorfer M; Bottero J; Baumgarten A; Bhagani S; Lacombe K; Nelson M; Rockstroh JK;
    J Hepatol; 2017 Feb; 66(2):282-287. PubMed ID: 27650285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis C in an HIV-infected patient: a case report and review of literature.
    Driver TH; Terrault N; Saxena V
    J Gen Intern Med; 2013 May; 28(5):734-8. PubMed ID: 23151989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment.
    Abdelrahman T; Hughes J; Main J; McLauchlan J; Thursz M; Thomson E
    Hepatology; 2015 Jan; 61(1):88-97. PubMed ID: 24797101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and treatment of acute hepatitis C virus infection in a United States population.
    Corey KE; Ross AS; Wurcel A; Schulze Zur Wiesch J; Kim AY; Lauer GM; Chung RT
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1278-82. PubMed ID: 16931171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.